-
Something wrong with this record ?
Quantification and significance of extraprostatic findings on prostate MRI: a retrospective analysis and three-tier classification
M. Wagnerova, I. Macova, P. Hanus, M. Jurka, O. Capoun, L. Lambert, A. Burgetova
Status not-indexed Language English Country Germany
Document type Journal Article
Grant support
MH CZ-DRO
Ministry of Health of the Czech Republic
General University Hospital in Prague-VFN
Ministry of Health of the Czech Republic
00064165
Ministry of Health of the Czech Republic
Cooperatio
Charles University in Prague
Medical Diagnostics
Charles University in Prague
Basic Medical Sciences
Charles University in Prague
NLK
Directory of Open Access Journals
from 2012
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
ProQuest Central
from 2012-08-01
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2012-01-01
Nursing & Allied Health Database (ProQuest)
from 2012-08-01
Health & Medicine (ProQuest)
from 2012-08-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
Springer Journals Complete - Open Access
from 2010-01-01
Springer Nature OA/Free Journals
from 2010-01-01
- Publication type
- Journal Article MeSH
OBJECTIVES: To quantify extraprostatic findings (EPFs) on prostate MRI, estimate the proportion of reported and unreported EPFs, assess their clinical importance, and propose standardized reporting of EPFs. MATERIALS AND METHODS: Prostate 3-T MRI studies, reports, and clinical data from 623 patients (age 67.9 ± 8.2 years) were retrospectively analyzed and re-evaluated for the presence of EPFs and their clinical significance: E1-no finding or findings that have no clinical significance; E2-potentially significant findings; and E3-significant findings. RESULTS: Secondary reading identified 1236 EPFs in 593 patients (1.98 ± 1.13 EPFs per patient, no EPFs in 30 patients), from which 468 (37.8%) were mentioned in the original report. The most common findings included diverticulosis (44% of patients), hydrocele (34%), inguinal fat hernia (16%), and bladder wall trabecular hypertrophy (15%). There were 80 (6.5%) E2 EPFs and 30 (2.4%) E3 EPFs. From E3 EPFs, 10 (33%) were not originally reported. A workup was suggested in 35 (52%) of the 67 originally reported E2 and E3 findings with follow-up and performed in 20 (30%). Fourteen (21%) EPFs in 11 patients influenced their management. Four experienced radiologists originally reported 1.8 to 2.5 findings per patient (p < 0.0001). CONCLUSIONS: EPFs on prostate MRI are frequent, but only 2.4% are clinically significant (E3), and 33% of these are not reported. Only 30% of E2 and E3 findings are further explored, and 21% influence patient management. We suggest that an "E" category should be attached to the PI-RADS system to identify the presence of EPFs that require further workup. CRITICAL RELEVANCE STATEMENT: Extraprostatic findings on prostate MRI are frequent, but only 2.4% are clinically significant (E3), and 33% of these are not reported. We advocate standardized reporting of extraprostatic findings indicating their clinical significance. KEY POINTS: • Extraprostatic findings on prostate MRI are frequent with an average of two findings per patient. • 2.4% of extraprostatic findings are significant, and 33% of these are not reported. • There is a significant variability among experienced radiologists in reporting extraprostatic findings.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022334
- 003
- CZ-PrNML
- 005
- 20240116163015.0
- 007
- ta
- 008
- 240105s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13244-023-01549-9 $2 doi
- 035 __
- $a (PubMed)38072909
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Wagnerova, Monika $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 245 10
- $a Quantification and significance of extraprostatic findings on prostate MRI: a retrospective analysis and three-tier classification / $c M. Wagnerova, I. Macova, P. Hanus, M. Jurka, O. Capoun, L. Lambert, A. Burgetova
- 520 9_
- $a OBJECTIVES: To quantify extraprostatic findings (EPFs) on prostate MRI, estimate the proportion of reported and unreported EPFs, assess their clinical importance, and propose standardized reporting of EPFs. MATERIALS AND METHODS: Prostate 3-T MRI studies, reports, and clinical data from 623 patients (age 67.9 ± 8.2 years) were retrospectively analyzed and re-evaluated for the presence of EPFs and their clinical significance: E1-no finding or findings that have no clinical significance; E2-potentially significant findings; and E3-significant findings. RESULTS: Secondary reading identified 1236 EPFs in 593 patients (1.98 ± 1.13 EPFs per patient, no EPFs in 30 patients), from which 468 (37.8%) were mentioned in the original report. The most common findings included diverticulosis (44% of patients), hydrocele (34%), inguinal fat hernia (16%), and bladder wall trabecular hypertrophy (15%). There were 80 (6.5%) E2 EPFs and 30 (2.4%) E3 EPFs. From E3 EPFs, 10 (33%) were not originally reported. A workup was suggested in 35 (52%) of the 67 originally reported E2 and E3 findings with follow-up and performed in 20 (30%). Fourteen (21%) EPFs in 11 patients influenced their management. Four experienced radiologists originally reported 1.8 to 2.5 findings per patient (p < 0.0001). CONCLUSIONS: EPFs on prostate MRI are frequent, but only 2.4% are clinically significant (E3), and 33% of these are not reported. Only 30% of E2 and E3 findings are further explored, and 21% influence patient management. We suggest that an "E" category should be attached to the PI-RADS system to identify the presence of EPFs that require further workup. CRITICAL RELEVANCE STATEMENT: Extraprostatic findings on prostate MRI are frequent, but only 2.4% are clinically significant (E3), and 33% of these are not reported. We advocate standardized reporting of extraprostatic findings indicating their clinical significance. KEY POINTS: • Extraprostatic findings on prostate MRI are frequent with an average of two findings per patient. • 2.4% of extraprostatic findings are significant, and 33% of these are not reported. • There is a significant variability among experienced radiologists in reporting extraprostatic findings.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Macova, Iva $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 700 1_
- $a Hanus, Petr $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 700 1_
- $a Jurka, Martin $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 700 1_
- $a Capoun, Otakar $u Department of Urology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 700 1_
- $a Lambert, Lukas $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic. lukas.lambert@vfn.cz $1 https://orcid.org/0000000322994707 $7 xx0145830
- 700 1_
- $a Burgetova, Andrea $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, 128 08, Czech Republic
- 773 0_
- $w MED00181719 $t Insights into imaging $x 1869-4101 $g Roč. 14, č. 1 (2023), s. 215
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38072909 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163012 $b ABA008
- 999 __
- $a ok $b bmc $g 2036243 $s 1208779
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 14 $c 1 $d 215 $e 20231210 $i 1869-4101 $m Insights into imaging $n Insights Imaging $x MED00181719
- GRA __
- $a MH CZ-DRO $p Ministry of Health of the Czech Republic
- GRA __
- $a General University Hospital in Prague-VFN $p Ministry of Health of the Czech Republic
- GRA __
- $a 00064165 $p Ministry of Health of the Czech Republic
- GRA __
- $a Cooperatio $p Charles University in Prague
- GRA __
- $a Medical Diagnostics $p Charles University in Prague
- GRA __
- $a Basic Medical Sciences $p Charles University in Prague
- LZP __
- $a Pubmed-20240105